HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

9- (2- chlorobenzyl)- 9H- carbazole- 3- carbaldehyde

Also Known As:

LCY-2-CHO

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Carbazoles: 32
        9-(2-chlorobenzyl)-9H-carbazole-3-carbaldehyde: 2
  - 3-Ring Heterocyclic Compounds
    - Carbazoles: 32
      - 9-(2-chlorobenzyl)-9H-carbazole-3-carbaldehyde: 2

Experts

1.	Chao, Yee: 2 articles (07/2007 - 07/2005)
2.	Ho, Feng-Ming: 2 articles (07/2007 - 07/2005)
3.	Huang, Li-Jiau: 2 articles (07/2007 - 07/2005)
4.	Lin, Wan-Wan: 2 articles (07/2007 - 07/2005)
5.	Chen, You-Ci: 1 article (07/2007)
6.	Kang, Hao-Cheng: 1 article (07/2007)
7.	Lee, Sho-Tone: 1 article (07/2007)
8.	Chang, Ying-Hsin: 1 article (07/2005)
9.	Chen, Chih-Ping: 1 article (07/2005)
10.	Hsu, Ming-Jen: 1 article (07/2005)

Related Diseases

1.	Atherosclerosis 07/15/2007 - "Taken together, given the overall anti-inflammatory properties of LCY-2-CHO in VSMC, in terms to induce HO-1 gene expression and inhibit inflammatory gene expression, these results highlight the therapeutic potential of LCY-2-CHO in atherosclerosis."
2.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/01/2005 - "Comparing the cell selectivity of LCY-2-CHO, we found T-cell acute lymphoblastic CEM leukemia cells were sensitive to 1 microM LCY-2-CHO, acute myeloid leukemia HL-60 cells underwent apoptosis at 10 microM, while adherent cancer cells, such as PC3, HT29 and MCF-7, were resistant to 30 microM LCY-2-CHO within 24-h incubation. "
3.	Neoplasms (Cancer) 07/01/2005 - "Comparing the cell selectivity of LCY-2-CHO, we found T-cell acute lymphoblastic CEM leukemia cells were sensitive to 1 microM LCY-2-CHO, acute myeloid leukemia HL-60 cells underwent apoptosis at 10 microM, while adherent cancer cells, such as PC3, HT29 and MCF-7, were resistant to 30 microM LCY-2-CHO within 24-h incubation. "
4.	Leukemia 07/01/2005 - "Cell cycle analysis by propidium iodide staining in human THP-1 monocytic leukemia cells showed the ability of LCY-2-CHO to increase cell population in sub-G1 stage with time- and concentration-dependent manners. " 07/01/2005 - "Comparing the cell selectivity of LCY-2-CHO, we found T-cell acute lymphoblastic CEM leukemia cells were sensitive to 1 microM LCY-2-CHO, acute myeloid leukemia HL-60 cells underwent apoptosis at 10 microM, while adherent cancer cells, such as PC3, HT29 and MCF-7, were resistant to 30 microM LCY-2-CHO within 24-h incubation. "

Related Drugs and Biologics

1.	Propidium (Propidium Iodide)
2.	Dihydrotachysterol (AT 10)